389 results on '"Polyak, Stephen J"'
Search Results
2. Latent tuberculosis is associated with heightened levels of pro-and anti-inflammatory cytokines among Kenyan men and women living with HIV on long-term antiretroviral therapy
3. Mechanism of enterovirus VP0 maturation cleavage based on the structure of a stabilised assembly intermediate.
4. Two-way pharmacodynamic modeling of drug combinations and its application to pairs of repurposed Ebola and SARS-CoV-2 agents
5. Postpartum metabolic syndrome after gestational hypertension and preeclampsia, a prospective cohort study
6. A unifying model to explain nirmatrelvir / ritonavir’s high efficacy during early treatment and low efficacy as post-exposure prophylaxis, and to predict viral rebound
7. Antiretroviral therapy reduces but does not normalize immune and vascular inflammatory markers in adults with chronic HIV infection in Kenya
8. Chemoselective fluorination and chemoinformatic analysis of griseofulvin: Natural vs fluorinated fungal metabolites
9. Metabolic syndrome and 10-year cardiovascular risk among HIV-positive and HIV-negative adults: A cross-sectional study
10. Modulation of in Vitro SARS-CoV-2 Infection by Stephania tetrandra and Its Alkaloid Constituents
11. A validated UHPLC-tandem mass spectrometry method for quantitative analysis of flavonolignans in milk thistle (Silybum marianum) extracts
12. Discovery of host-directed modulators of virus infection by probing the SARS-CoV-2–host protein–protein interaction network
13. Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2
14. Arbidol as a broad-spectrum antiviral: An update
15. The Antiviral Drug Arbidol Inhibits Zika Virus
16. Discovery of host-directed modulators of virus infection by probing the SARSCoV-2-host protein-protein interaction network
17. Semisynthesis, cytotoxicity, antiviral activity, and drug interaction liability of 7-O-methylated analogues of flavonolignans from milk thistle
18. Enhanced bioactivity of silybin B methylation products
19. Mono- and combinational drug therapies for global viral pandemic preparedness
20. Mono- and combinational drug therapies for global viral pandemic preparedness
21. Response of Human Liver Tissue to Innate Immune Stimuli
22. Identification of hepatoprotective flavonolignans from silymarin
23. Functional Characterization of Core Genes from Patients with Acute Hepatitis C Virus Infection
24. Treatment of Chronic Hepatitis C Virus Infection: A Clinical and Virological Perspective
25. Broad-spectrum mono- and combinational drug therapies for global viral pandemic preparedness
26. Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses
27. Evaluation of the potential of botanicals and their constituents against the SARS-CoV-2 virus
28. Hepatitis C Virus-Specific Immune Responses and Quasi-Species Variability at Baseline Are Associated with Nonresponse to Antiviral Therapy during Advanced Hepatitis C
29. Stability of CXCL-8 and Related AU-Rich mRNAs in the Context of Hepatitis C Virus Replication in vitro
30. Arenavirus Replication : Molecular Dissection of the Role of Viral Protein and RNA
31. Silymarin Inhibits In Vitro T-Cell Proliferation and Cytokine Production in Hepatitis C Virus Infection
32. HCV Research 20 Years After Discovery: A Summary of the 16th International Symposium on Hepatitis C Virus and Related Viruses
33. The Protein Kinase-Interacting Domain in the Hepatitis C Virus Envelope Glycoprotein-2 Gene Is Highly Conserved in Genotype 1-Infected Patients Treated with Interferon
34. Central obesity is a contributor to systemic inflammation and monocyte activation in virally suppressed adults with chronic HIV in Kenya
35. Erratum for Herring et al., “Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs”
36. Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses
37. Assessment of Hepatitis C Virus Quasispecies Heterogeneity by Gel Shift Analysis: Correlation with Response to Interferon Therapy
38. Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs
39. CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice
40. Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
41. Liver Abnormalities after Elimination of HCV Infection: Persistent Epigenetic and Immunological Perturbations Post-Cure
42. Response of human liver tissue to innate immune stimuli
43. Human Immunodeficiency Virus Is Associated With Higher Levels of Systemic Inflammation Among Kenyan Adults Despite Viral Suppression
44. Arbidol inhibits viral entry by interfering with clathrin-dependent trafficking
45. The Circulatory Orbit of Micro-Rnas in Hepatitis C
46. Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection
47. Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B
48. Myeloid Suppressor Cells Induced by Hepatitis C Virus Suppress T-Cell Responses Through the Production of Reactive Oxygen Species
49. Antiretroviral therapy reduces but does not normalize immune and vascular inflammatory markers in adults with chronic HIV infection in Kenya
50. Postpartum metabolic syndrome and high‐sensitivity C‐reactive protein after gestational hypertension and pre‐eclampsia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.